학술논문

Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; JUN 15 2022, 28 12, p2536-p2546, 11p.
Subject
Language
English
ISSN
15573265